Page last updated: 2024-11-04

vorinostat and Hypesthesia

vorinostat has been researched along with Hypesthesia in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.

Research Excerpts

ExcerptRelevanceReference
"Hypoesthesia is a clinical feature of neuropathic pain."1.39HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. ( Araki, K; Matsushita, Y; Mukae, T; Omotuyi, Oi; Ueda, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsushita, Y1
Araki, K1
Omotuyi, Oi1
Mukae, T1
Ueda, H1

Other Studies

1 other study available for vorinostat and Hypesthesia

ArticleYear
HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model.
    British journal of pharmacology, 2013, Volume: 170, Issue:5

    Topics: Acetylation; Analgesics; Animals; Chromatin Assembly and Disassembly; Disease Models, Animal; Epigen

2013